For all official information and updates regarding COVID-19, visit the South African Department of Health website at wwwsacoronaviruscoza
Russia’s Sputnik V COVID-19 vaccine has sought regulatory approval to launch phase 3 trials in Brazil, Brazilian health regulator Anvisa said Tuesday evening
The Sputnik vaccine is developed by the Gamaleya Research Institute in Moscow and marketed by the Russian Direct Investment Fund (RDIF)
The state of Parana in southern Brazil has already agreed to test and produce the Russian vaccine, while the state of Bahia in the northeast is planning to participate in trials and buy vaccine doses
Phase 3 trials are considered the gold standard because patients are randomized to receive either treatment with the drug being tested or a placebo, without participants or physicians knowing which group they belong to.
Vaccine, Brazil, Jair Bolsonaro, Coronavirus, AstraZeneca
Ebene News – GB – Russian vaccine Sputnik requests phase 3 study in Brazil – SABC News – Latest news , special reports, world, business, sports coverage of all current events in South Africa Leader in African news